We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
» Medtronic Issues Alert About Heart Devices
Medtronic Issues Alert About Heart Devices
September 11, 2009
Medtronic has sent out an alert about 6,300 Concerto CRT-D and Virtuoso ICD implantable heart devices.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Add this article to your cart for $10.00
Upcoming Events
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
23
May
Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Bristol Myers’, J&J’s Challenges to Medicare Drug Price Negotiations Squashed
Public Input on Advisory Committee Processes Sought by FDA
300 ‘Junk Patents’ Targeted by FTC With Warning Letters, Including Ozempic
FDA Identifies Two Class I Recalls for SonarMed Airway Monitors, One for BioMérieux Test Kits
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More